Corinth MedTech, a small startup company located in Cupertino, CA, and founded in 2014, developed a bipolar transurethral and transcervical resection system intended for endoscopically controlled tissue removal for male patients diagnosed with benign prostatic hyperplasia (BPH), and female patients diagnosed with Abnormal Uterine Bleeding (AUB), fibroids and/or polyps requiring Hysteroscopic tissue removal.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 06/25/19 | $12,000,000 | Series D |
Aethan Capital ShangBay Capital | undisclosed |
